University of Calgary
2500 University Drive NW, Calgary, Alberta, T2N 1N4, Canada
Overview
The University of Calgary is Canada’s leading next-generation university – a living, growing and youthful institution that embraces change and opportunity with a can-do attitude. Located in the nation’s most enterprising city, the university has a clear strategic direction – Eyes High – to become one of Canada’s top five research universities by 2016, grounded in innovative learning and teaching and fully integrated with the community of Calgary. As a comprehensive academic and research institution, the University of Calgary inspires and supports discovery, creativity and innovation across all disciplines. Through the Taylor Institute for Teaching and Learning, under construction now, the university will take the lead in educational innovation by researching the most effective methods for engaging students, by supporting faculty to be the best teachers they can be and by providing some of the most innovative learning spaces available anywhere in North America. The University of Calgary attracts and nurtures the talent that drives new knowledge creation, improves lives and betters our world. In this rich learning environment, the university serves over 31,000 students in more than 200 undergraduate, graduate and professional degree programs, and provides the community with diverse lifelong learning opportunities. International study, volunteer, work, and research programs provide global context while promoting diversity and excellence in learning, teaching and research. The University of Calgary stands out among Canadian universities in how it actively engages students in leadership development in all areas – the arts, athletics, science, medicine, engineering, volunteerism and business. It is also a leader in sustainability with its set of values embraced by the campus through teaching, leadership and campus operations.
- Total investments
- 2
- Lead investments
- 1
- Investments · 12mo
- 0
- Active investors
- 8
Sector focus
- Education
Investment portfolio
- Noa Therapeutics
Led · Seed · Mar 2024
Noa Therapeutics, founded in 2022 and based in Toronto, uses a computer-assisted drug discovery engine to identify multimodal therapeutic compounds for immune diseases. The pre-clinical startup is developing a portfolio of non-steroidal compounds that target immune modulation, barrier restoration, and microbiome modulation. Its lead program is directed at atopic dermatitis, and the company is also advancing work aimed at barrier-dysfunction inflammatory diseases such as ulcerative colitis and inflammatory bowel disease. Noa is a resident company of Johnson & Johnson’s JLABS Toronto within the MaRS Discovery District. The company was co-founded by CEO Carla Spina and CSO Serena Mandla and has announced a board that includes Maura Campbell and François Ravenelle. The new funding will support advancing the lead candidate and the hit-to-lead phase to optimize promising molecules into potential drugs.
- Areto Labs
Participated · Seed · Jun 2022
Areto Labs builds a B2B cybersecurity platform that detects and counteracts online abuse using machine learning. Its software identifies and monitors abusive content and executes automated counteractions such as muting, blocking, and reporting offending accounts. The product leverages ML techniques including sentiment analysis and natural language processing to surface abuse and enable automated responses. Areto Labs plans to use its pre-seed proceeds to grow its product team, invest in research and development, and expand sales to sports teams and organizations across Canada and Europe. Founded in 2020, the company lists Cuthbertson, COO Kasey Machin, and CPO Jacqueline Comer among its founding leadership. Financially, Areto Labs secured $1.0M in pre-seed funding via SAFE in June 2022.